What is the most immediate intervention for an 18-year-old patient presenting with palpitations and tachycardia, with an electrocardiogram (ECG) showing a regular narrow complex tachycardia with a heart rate of 176 beats per minute (bpm)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The most immediate intervention for this 18-year-old patient with palpitations, rapid heart rate, and ECG showing regular narrow complex tachycardia at 176 bpm is to attempt vagal maneuvers, as recommended by the 2015 ACC/AHA/HRS guideline for the management of adult patients with supraventricular tachycardia 1. These include having the patient perform a Valsalva maneuver (bearing down as if having a bowel movement) or carotid sinus massage (if no contraindications like carotid bruits). The technique for the Valsalva maneuver involves the patient raising intrathoracic pressure by bearing down against a closed glottis for 10 to 30 seconds, equivalent to at least 30 mm Hg to 40 mm Hg 1. Carotid massage is performed after absence of bruit has been confirmed by auscultation, by applying steady pressure over the right or left carotid sinus for 5 to 10 seconds 1. If vagal maneuvers fail, the next step would be administering adenosine 6 mg as a rapid IV push followed by a saline flush, as it can acutely terminate AVNRT in approximately 95% of patients 1. Adenosine works by temporarily blocking AV nodal conduction, which can terminate the tachycardia if it's a reentrant rhythm like AVNRT or AVRT. This approach is appropriate because the narrow complex and regular rhythm suggest a supraventricular tachycardia (SVT), which is common in young patients. While administering these interventions, ensure continuous cardiac monitoring, have resuscitation equipment available, and maintain IV access. If the patient becomes hemodynamically unstable at any point (hypotension, altered mental status), synchronized cardioversion would become the immediate intervention instead, as recommended by the guideline 1. Key points to consider in the management of this patient include:

  • The importance of attempting vagal maneuvers first, due to their simplicity, safety, and effectiveness 1
  • The use of adenosine as a second-line treatment, given its high success rate in terminating AVNRT 1
  • The need for continuous monitoring and readiness to perform synchronized cardioversion if the patient becomes hemodynamically unstable 1

From the FDA Drug Label

ADENOSINE INJECTION, USP for intravenous use INDICATIONS AND USAGE Adenosine Injection, a pharmacologic stress agent, is indicated as an adjunct to thallium-201 myocardial perfusion scintigraphy in patients unable to exercise adequately ( 1) DOSAGE AND ADMINISTRATION Recommended dose is 0.14 mg/kg/min infused over six minutes as a continuous peripheral intravenous infusion (total dose of 0. 84 mg/kg) ( 2) WARNINGS AND PRECAUTIONS • Cardiac Arrest, Ventricular Arrhythmias, and Myocardial Infarction. Fatal cardiac events have occurred. Avoid use in patients with symptoms or signs of acute myocardial ischemia.

The most immediate intervention for a patient with a regular narrow complex tachycardia is adenosine administration. The recommended dose is 0.14 mg/kg/min infused over six minutes. However, it is crucial to consider the warnings and precautions, especially regarding cardiac arrest, ventricular arrhythmias, and myocardial infarction. Given the patient's symptoms, adenosine may be considered, but it is essential to be cautious and prepared for potential adverse reactions 2.

Key considerations:

  • Contraindications: Second- or third-degree AV block, sinus node disease, known or suspected bronchoconstrictive or bronchospastic lung disease, and known hypersensitivity to adenosine injection.
  • Warnings and precautions: Cardiac arrest, ventricular arrhythmias, and myocardial infarction, sinoatrial and atrioventricular nodal block, bronchoconstriction, hypotension, cerebrovascular accidents, seizures, and hypersensitivity.

From the Research

Immediate Intervention for Supraventricular Tachycardia

The patient presents with palpitations and a rapid heart rate, and the ECG shows a regular narrow complex tachycardia with a heart rate of 176/min. The most immediate intervention for this condition can be determined based on the provided studies.

Vagal Maneuvers

  • Vagal maneuvers, including the Valsalva maneuver, carotid massage, and ice to the face, are commonly used to terminate supraventricular tachycardias (SVTs) 3.
  • The Valsalva maneuver and carotid sinus massage (CSM) have been compared in several studies, with varying results:
    • One study found that the Valsalva maneuver had a success rate of 19.4%, while CSM had a success rate of 10.5% 4.
    • Another study found that the modified Valsalva maneuver (mVM) had a higher success rate than CSM, with a success rate of 43.7% for mVM and 9.1% for CSM 5.
    • A systematic review and meta-analysis found that the Valsalva maneuver had a higher success rate than CSM, with a risk ratio of 1.82 (95% CI: 1.29-2.57, p<0.001) 6.

Electrical Cardioversion

  • Hemodynamically unstable patients with SVTs should be treated with electrical cardioversion 3.
  • If the patient is stable, acute termination of tachycardia can be achieved by vagal maneuvers or medical therapy 3.

Recommendation

Based on the provided studies, the most immediate intervention for the patient with a regular narrow complex tachycardia and a heart rate of 176/min would be to attempt vagal maneuvers, such as the Valsalva maneuver or carotid massage, to terminate the SVT. If the patient is hemodynamically unstable, electrical cardioversion should be considered 3, 5, 4, 6.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.